Atraverse Medical Reports the US FDA’s Clearance of Hotwire Left Heart Access Device
Shots:
- The US FDA has granted clearance to the company’s Hotwire radiofrequency (RF) guidewire device facilitating zero exchange left-heart access and serving as a rail for catheter-based therapy systems
- The Hotwire system offers universal sheath compatibility and optimized RF technology to enhance patient outcomes and for efficient procedural workflows
- Atraverse also generated funding of $12.5M in total seed investment led by physicians, venture investors and medtech entrepreneurs to support the company’s research, development & commercialization activities
Ref: PR Newswire | Image: Atraverse Medical
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
